Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Acromegaly - Part 1: Diagnostic and Clinical Issues.
Cozzi R, Ambrosio MR, Attanasio R, Bozzao A, De Marinis L, De Menis E, Guastamacchia E, Lania A, Lasio G, Logoluso F, Maffei P, Poggi M, Toscano V, Zini M, Chanson P, Katznelson L. Cozzi R, et al. Among authors: lasio g. Endocr Metab Immune Disord Drug Targets. 2020;20(8):1133-1143. doi: 10.2174/1871530320666200127103320. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 31985386 Free PMC article. Review.
Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Acromegaly - Part 2: Therapeutic Issues.
Cozzi R, Ambrosio MR, Attanasio R, Bozzao A, De Marinis L, De Menis E, Guastamacchia E, Lania A, Lasio G, Logoluso F, Maffei P, Poggi M, Toscano V, Zini M, Chanson P, Katznelson L. Cozzi R, et al. Among authors: lasio g. Endocr Metab Immune Disord Drug Targets. 2020;20(8):1144-1155. doi: 10.2174/1871530320666200129113328. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 31995025 Free PMC article. Review.
Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors.
Cozzi R, Ambrosio MR, Attanasio R, Battista C, Bozzao A, Caputo M, Ciccarelli E, De Marinis L, De Menis E, Faustini Fustini M, Grimaldi F, Lania A, Lasio G, Logoluso F, Losa M, Maffei P, Milani D, Poggi M, Zini M, Katznelson L, Luger A, Poiana C. Cozzi R, et al. Among authors: lasio g. Eur J Endocrinol. 2022 Feb 3;186(3):P1-P33. doi: 10.1530/EJE-21-0977. Eur J Endocrinol. 2022. PMID: 35000899 Free PMC article.
AME Position Statement on clinical management of acromegaly.
Cozzi R, Baldelli R, Colao A, Lasio G, Zini M, Attanasio R; Italian Association of Clinical Endocrinologists (AME). Cozzi R, et al. Among authors: lasio g. J Endocrinol Invest. 2009;32(6 Suppl):2-25. J Endocrinol Invest. 2009. PMID: 19923883 Review. No abstract available.
Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage.
Cozzi R, Montini M, Attanasio R, Albizzi M, Lasio G, Lodrini S, Doneda P, Cortesi L, Pagani G. Cozzi R, et al. Among authors: lasio g. J Clin Endocrinol Metab. 2006 Apr;91(4):1397-403. doi: 10.1210/jc.2005-2347. Epub 2006 Jan 31. J Clin Endocrinol Metab. 2006. PMID: 16449332 Clinical Trial.
83 results